SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and intense community debate as the token's massive price surge triggers accusations of market manipulation and pump-and-dump schemes, while supporters point to upcoming global music events and utility as catalysts for long-term growth. Investors remain sharply divided, with some actively trading the short squeezes and liquidations, while others issue urgent warnings about concentrated token ownership and the high risk of a potential collapse.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is gaining momentum as investors position it as an under-the-radar micro-cap play within the competitive AI and Web3 infrastructure sector. The community is actively debating its long-term potential compared to established GPU-compute projects, with many highlighting its perceived growth trajectory and early-stage status as key catalysts for engagement.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus is trending as its community emphasizes long-term organic growth and viral culture over short-term hype during recent market volatility. Investors are actively discussing the token's resilience and its strategic partnerships within the Solana memecoin ecosystem as they build toward future milestones.

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. Its products include lipsticks, makeup brushes, mascara, eyelash curlers, and makeup brush cleansers. The company was founded by Oran Holtzman and Shiran Holtzman-Erel on March 23, 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd. - Ordinary Shares - Class A

ODDITY Tech is currently trending as investors weigh a major share buyback program and aggressive insider purchasing by the CEO against bearish technical signals and concerns over revenue guidance. The community is actively debating whether the stocks recent volatility presents a deep value opportunity or if ongoing macroeconomic and sector-specific risks will drive shares lower.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares (LABU) is actively trending as investors flock to the biotech sector amidst a mix of buyout activity, optimism surrounding AI-driven drug discovery, and a broader market rotation into small-cap and healthcare equities. The community remains deeply divided, with some traders highlighting the ETF's recent aggressive price appreciation as an indicator of a potential parabolic blow-off top, while others continue to bet on further gains driven by anticipated Federal Reserve interest rate policy changes.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares (LABD) is experiencing heavy retail activity as traders weigh ongoing geopolitical instability and sector-specific volatility against the broader market's bullish momentum. The community is actively debating the sustainability of the XBI index's recent price levels, with many traders strategically averaging down or scalping intraday moves while waiting for a anticipated technical reversal in biotech valuations.

Highstreet

Highstreet is experiencing intense community debate, with some traders optimistic about a potential short squeeze given the token's significant retracement from previous highs, while skeptics warn of volatility and erratic price action. Discussion is heavily focused on whale accumulation patterns and the potential for a rebound as participants speculate on whether the current entry point represents a discount or a continued downward trend.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as investors react to a significant Trump-led executive order that fast-tracks the review of psychedelic-based mental health treatments. While the community is actively debating the potential for an FDA fast-track for COMP360 and whether the regulatory tailwinds will drive a market re-rating, sentiment remains divided between those expecting a major sector-wide surge and skeptics urging caution regarding long-term clinical timelines and management execution.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco Corp is surging following the announcement of a massive strategic partnership with Brookfield and the U.S. government to invest billions into new nuclear reactor deployment to meet AI energy demands. The community is heavily focused on this shift toward nuclear as essential infrastructure for data centers, with many traders riding the momentum while debating whether the stock's parabolic move is overextended or just the beginning of a long-term supply bottleneck play.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is generating significant conversation as traders pivot between optimistic staking accumulation and aggressive short-term trading of volatile meme coins. The community remains focused on potential regulatory catalysts and ecosystem expansion, while debates continue over whether to treat the current price action as a structural bottom or a trap for retail investors.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kodiak Sciences (NASDAQ:KOD) Stock Price Up 9.8%  - What's Next?

Kodiak Sciences (NASDAQ:KOD) Trading 9.8% Higher - Here's What Happened...

Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Up 39.8% in March

Kodiak Sciences Inc. (NASDAQ:KOD - Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totaling 9,854,423 shares...

Kodiak Sciences (NASDAQ:KOD) Stock Price Down 5.5% - Should You Sell?

Kodiak Sciences (NASDAQ:KOD) Shares Down 5.5% - What's Next...

Kodiak Sciences (NASDAQ:KOD) Hits New 52-Week High  - Here's What Happened

Kodiak Sciences (NASDAQ:KOD) Sets New 52-Week High - Should You Buy...

Kodiak Sciences (NASDAQ:KOD) Trading Up 3.7% - Here's What Happened

Kodiak Sciences (NASDAQ:KOD) Trading 3.7% Higher - Here's What Happened...

Lifesci Capital Forecasts Lower Earnings for Kodiak Sciences

Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) - Stock analysts at Lifesci Capital decreased their Q1 2026 earnings estimates for Kodiak Sciences in a research report issued to clients and investors on Wednesday, April 1st. Lifesci Capital analyst P. Dolezal now anticipates that the company will ea...

Q1 EPS Estimates for Kodiak Sciences Decreased by Analyst

Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) - HC Wainwright cut their Q1 2026 EPS estimates for Kodiak Sciences in a research report issued on Wednesday, April 1st. HC Wainwright analyst M. Caufield now anticipates that the company will earn ($0.94) per share for the quarter, down from their pre...

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus

KOD posts wider Q4 loss. However, its pipeline advances, with strong phase III data for Zenkuda driving accelerated regulatory plans.

Kodiak Sciences (NASDAQ:KOD) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Kodiak Sciences (NASDAQ:KOD - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($1.04) EPS for the quarter, missing the consensus estimate of ($1.02) by ($0.02...

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025...

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Current Price	$44.90
Prev Close	$40.41
Open	$42.35
Dividend Yield	0.00%
50-Day Moving Average	$29.67
Beta	1.89
Avg. Volume	1.58M
PE Ratio	-10.39

52-Week High	$46.67
52-Week Low	$2.81
Market Capitalization	$2.78B
EPS (Annual)	-$4.32
Price to Book	17.62
Revenue Per Employee	$0.00

KOD
Kodiak Sciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KOD News

KODKodiak Sciences Inc